PLRX Q1 2023 Earnings — Pliant Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PLRXPliant Therapeutics, Inc.

$85M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M+6.6% YoY

Gross Profit

$271,00020.3% margin

Operating Income

-$42M-3160.3% margin

Net Income

-$38M-2818.9% margin

EPS (Diluted)

$-0.50

QoQ Revenue Growth

-32.2%

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$30M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$598M

Total Liabilities

$36M

Stockholders' Equity

$562M

Cash & Equivalents

$103M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$1M	+6.6%
Gross Profit	$271,000	$1M	-78.3%
Operating Income	-$42M	-$28M	-49.2%
Net Income	-$38M	-$28M	-33.6%